NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at assumed coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research report report published on Thursday morning. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Stock Performance Shares of NYSE:NBY opened at $0.32 on Thursday. NovaBay Pharmaceuticals has a 12-month low of $0.30 and a 12-month high of […]

Leave a Reply

Your email address will not be published.

Previous post NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at
Next post Selecta Biosciences (NASDAQ:SELB) Now Covered by